Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Hyodo

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|April 29, 2006
Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancerToyoaki Uchida, Hiroshi Ohkusa, Hideyuki Yamashita, et al.
Metabolism: Clinical and Experimental|August 31, 2004
Effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patientsAyako Ikejiri, Tsutomu Hirano, Satoru Murayama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 15, 2006
Ammonium acid urate urolithiasis in JapanHidetoshi Kuruma, Takashi Arakawa, Seiichi Kubo, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 24, 2014
Increase in the dosage amount of vitamin D3 preparations by switching from calcium carbonate to lanthanum carbonateToru Hyodo, Junko Kawakami, Noriko Mikami, et al.
Renal Replacement Therapy|October 18, 2021
Impact of the third wave of the COVID-19 pandemic and interventions to contain the virus on society and patients with kidney disease in CambodiaTam Nov, Toru Hyodo, Yukie Kitajima, et al.
Renal Replacement Therapy|June 22, 2022
Retraction Note: Impact of the third wave of the COVID-19 pandemic and interventions to contain the virus on society and patients with kidney disease in CambodiaTam Nov, Toru Hyodo, Yukie Kitajima, et al.
BMC Infectious Diseases|November 15, 2022
Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patientsHaruki Wakai, Natsumi Abe, Touno Tokuda, et al.
Clinical Calcium|November 8, 2005
[Treatment of adynamic bone disease with the complete replacement from calcium carbonate to sevelamer hydrochloride]Toru Hyodo, Haruki Wakai, Toru Takemura, et al.
American Journal of Nephrology|December 27, 2022
Serum Sclerostin Levels and Mortality in Hemodialysis Patients: An 8-Year Prospective StudyYosuke Nakagawa, Hirotaka Komaba, Takehiko Wada, et al.
Nephron. Clinical Practice|May 11, 2006
Immediate effect of Shakuyaku-kanzo-to on muscle cramp in hemodialysis patientsToru Hyodo, Takayasu Taira, Toru Takemura, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Urology : Official Journal of the Japanese Urological Association|April 29, 2006
Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancerToyoaki Uchida, Hiroshi Ohkusa, Hideyuki Yamashita, et al.
Metabolism: Clinical and Experimental|August 31, 2004
Effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patientsAyako Ikejiri, Tsutomu Hirano, Satoru Murayama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 15, 2006
Ammonium acid urate urolithiasis in JapanHidetoshi Kuruma, Takashi Arakawa, Seiichi Kubo, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 24, 2014
Increase in the dosage amount of vitamin D3 preparations by switching from calcium carbonate to lanthanum carbonateToru Hyodo, Junko Kawakami, Noriko Mikami, et al.
Renal Replacement Therapy|October 18, 2021
Impact of the third wave of the COVID-19 pandemic and interventions to contain the virus on society and patients with kidney disease in CambodiaTam Nov, Toru Hyodo, Yukie Kitajima, et al.
Renal Replacement Therapy|June 22, 2022
Retraction Note: Impact of the third wave of the COVID-19 pandemic and interventions to contain the virus on society and patients with kidney disease in CambodiaTam Nov, Toru Hyodo, Yukie Kitajima, et al.
BMC Infectious Diseases|November 15, 2022
Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patientsHaruki Wakai, Natsumi Abe, Touno Tokuda, et al.
Clinical Calcium|November 8, 2005
[Treatment of adynamic bone disease with the complete replacement from calcium carbonate to sevelamer hydrochloride]Toru Hyodo, Haruki Wakai, Toru Takemura, et al.
American Journal of Nephrology|December 27, 2022
Serum Sclerostin Levels and Mortality in Hemodialysis Patients: An 8-Year Prospective StudyYosuke Nakagawa, Hirotaka Komaba, Takehiko Wada, et al.
Nephron. Clinical Practice|May 11, 2006
Immediate effect of Shakuyaku-kanzo-to on muscle cramp in hemodialysis patientsToru Hyodo, Takayasu Taira, Toru Takemura, et al.
Pageof 4